{
    "title": "111_hr6389",
    "content": "The Act may be cited as the \"Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010\" or the \"PROSTATE Act\". Congress finds that prostate cancer is a significant health issue, being the second leading cause of cancer death among men. In 2009, over 190,000 new cases were diagnosed, resulting in more than 27,000 deaths. Approximately 2,000,000 Americans are living with prostate cancer. The disease can affect younger men and has racial disparities, with African-Americans having higher mortality rates. Rural populations also face challenges in accessing quality care, highlighting the need for innovative solutions like telehealth. Prostate cancer disparities exist among rural populations, with higher mortality rates compared to urban areas. Telehealth can improve access to quality care. Urologists play a key role in diagnosing and treating prostate cancer. Many unanswered questions remain regarding disease etiology and treatment differentiation. Overtreatment is a concern due to the lack of accurate early detection methods. Prostate cancer research aims to address the lack of accurate early detection methods, leading to significant overtreatment and unnecessary costs in healthcare systems. Prostate cancer research and health care programs in high volume, high cost areas should be coordinated to improve accountability and encourage the translation of research into practice for effective prevention, diagnosis, and treatment of the disease. SEC. 3. PROSTATE CANCER COORDINATION AND EDUCATION. The Secretary of Veterans Affairs, in collaboration with the Secretary of Defense and the Secretary of Health and Human Services, must establish an Interagency Prostate Cancer Coordination and Education Task Force within 180 days. The Task Force is responsible for summarizing advances in prostate cancer research, compiling best practices for adoption in health care programs, considering guidance for screening men over 74 on a case-by-case basis, and coordinating information on Federal research and health care program activities. The Interagency Prostate Cancer Coordination and Education Task Force aims to enable physicians to screen men over 74 on a case-by-case basis, share information on research and health care programs, develop a comprehensive strategy, and advise federal agencies on collaborative research and health care initiatives. The Interagency Prostate Cancer Coordination and Education Task Force aims to develop a comprehensive strategy for collaborative research and health care programs related to prostate cancer. This includes advising federal agencies on innovative approaches, key research questions, methodologies, and ensuring consistent action. They also aim to coordinate messages on screening and treatment for prostate cancer in educational materials for Federal health programs. The Prostate Cancer Task Force will develop recommendations for changes in research and health care programs of federal agencies to support research priorities. The Prostate Cancer Task Force aims to ensure strategic planning for research and health care programs across federal agencies, prevent duplication, increase public participation, disseminate information on progress, and enhance partnerships between public and private entities. The Prostate Cancer Task Force focuses on strategic planning for research and health care programs, dissemination of progress information, and enhancing partnerships between public and private entities. It also aims to identify cost savings, recommend promising efforts, prioritize action items, and determine funding needs for implementing recommendations. The Prostate Cancer Task Force, composed of representatives from various federal agencies, aims to coordinate a uniform message on prostate cancer screening and treatment. Expert advisory panels are appointed to assist in strategic planning, dissemination of progress information, and determining funding needs for implementing recommendations. The Prostate Cancer Task Force appoints expert advisory panels from medical, research, and delivery communities to provide input on prostate cancer diagnosis, treatment, and research. They convene meetings at least twice a year and submit recommendations to Congress. The Prostate Cancer Task Force meets at least twice a year and submits recommendations to Congress. The Federal Advisory Committee Act applies to the Task Force, with an exception regarding the termination of advisory committees. The Prostate Cancer Task Force meets regularly and provides recommendations to Congress. The Task Force is subject to the Federal Advisory Committee Act, with an exception for advisory committee termination. Section 4 focuses on prostate cancer research. The Secretary of Veterans Affairs, in coordination with other departments, will establish a program to intensify prostate cancer research. This program aims to develop better diagnostic methods, understand the causes of the disease, and expand basic research into prostate cancer. The Prostate Cancer Scientific Advisory Board is established to accelerate research data sharing and the movement of new medicines to patients. Additionally, there is a focus on expanding basic research, identifying novel agents for prevention and treatment, establishing clinical registries, and utilizing appropriate imaging modalities. The Office of the Chief Scientist of the FDA establishes a Prostate Cancer Scientific Advisory Board to accelerate research data sharing and the movement of new medicines to patients. The Underserved Minority Grant Program aims to address disparities in prostate cancer incidence and mortality rates among minorities, barriers to care and clinical trial participation, and the need for outreach and education in underserved communities. The Prostate Cancer Scientific Advisory Board aims to address barriers in access to care and participation in clinical trials specific to underserved minorities and men with a family history of prostate cancer. Outreach and educational efforts are needed to raise awareness in these communities, along with appropriate access to imaging modalities. The Telehealth and Rural Access Pilot Project is established. The Secretary of Veterans Affairs will establish four-year telehealth pilot projects to analyze clinical outcomes and cost effectiveness in underserved populations, including African-Americans, Latin-Americans, American Indians, and rural areas. Eligible entities will be selected with priority given to those in medically underserved areas. The Secretary will prioritize eligible entities in medically underserved areas, including African-Americans, Latin-Americans, and facilities of the Indian Health Service, for telehealth pilot projects. The evaluation will focus on the effective delivery of care for prostate cancer using telehealth services in underserved and tribal areas, improving the capacity of nonmedical providers, and exploring innovative medical home models. The Secretary will prioritize eligible entities in medically underserved areas, including African-Americans, Latin-Americans, and facilities of the Indian Health Service, for telehealth pilot projects focusing on providing health services for prostate cancer. The evaluation will explore innovative medical home models with collaboration between urologists, oncologists, radiologists, and primary care teams, as well as the effectiveness of using telehealth services for prostate cancer treatment in underserved areas. A report on the outcomes of the pilot projects, including cost savings and recommendations for expanding telehealth services, will be submitted to Congress within 12 months. The Secretary of Veterans Affairs will develop a national education campaign for prostate cancer, focusing on encouraging men to seek screening. The campaign will target communities with racial disparities in prostate cancer rates and men with a family history of the disease. Grants will be awarded to nonprofit entities for testing alternative outreach strategies. Authorization of appropriations is provided for the campaign. Authorization of appropriations is provided for a national education campaign on prostate cancer for fiscal years 2011 through 2015."
}